title: Safety of subcutaneous enoxaparin as ancillary therapy in STEMI patients receiving fibrinolysis.
authors: Department of Medicine, Hadassah-Hebrew University Medical Center, Mt. Scopus, Jerusalem, Israel. Electronic address: drott@hadassah.org.il.
authors: David
authors: D
authors: Rott
authors: David
authors: D
authors: Leibowitz
mesh_terms: D000328:Adult; D017984:Enoxaparin / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects* / Q000502:physiology; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis / Q000188:drug therapy*; D011446:Prospective Studies
chemical_list: D017984:Enoxaparin; D005343:Fibrinolytic Agents
keywords: Alteplase; Hemoglobin drop; Myocardial infarction